Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Canadian trials of ISAtx-247 commence in psoriasis patients

Oct. 5, 2001

FDA approves Dermagraft living human dermal substitute

Oct. 4, 2001

Skin repair trial for sun damage set to begin with NV-07a

Oct. 2, 2001

Full enrollment reached in Vasogen psoriasis trial

Sep. 28, 2001

Potent new p38 MAP kinase inhibitor suppresses cytokine release, skin inflammation

Sep. 27, 2001

Final phase I/II clinical data presented at European psoriasis meeting for siplizumab

Sep. 25, 2001

Broad development program under way for siplizumab

Sep. 19, 2001

Castor oil component demonstrates both pro- and antiinflammatory properties

Sep. 18, 2001

Allergan's Botox cleared in Canada for treatment of axillary hyperhidrosis

Sep. 13, 2001

Antiscarring PCP inhibitors in the Pfizer pipeline

Sep. 12, 2001

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...